Previous Close | 20.20 |
Open | 19.80 |
Bid | 20.20 x 50000 |
Ask | 21.40 x 50000 |
Day's Range | 19.80 - 19.80 |
52 Week Range | 18.71 - 31.26 |
Volume | |
Avg. Volume | 0 |
Market Cap | 1.316B |
Beta (5Y Monthly) | 0.31 |
PE Ratio (TTM) | 33.56 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.37 (1.85%) |
Ex-Dividend Date | Feb 29, 2024 |
1y Target Est | N/A |
LONDON, February 22, 2024--Genus (LSE:GNS), a leading global animal genetics company, today announces its interim results for the six months ended 31 December 2023. The full report has been made available on the investors section of the Genus plc website. The Company will discuss its corporate, operational and financial highlights in a pre-recorded webcast at 7:01 AM GMT, 2.01 EST.
FatBrain AI (LZG International, Inc., OTCMKTS: LZGI) (the "Company," or "we"), the leader in powerful and easy-to-use AI solutions and Genius Group Limited (NYSE American: GNS) ("Genius Group"), a leading entrepreneur edtech and education group, today signed a definitive merger agreement to power ecosystems of tomorrow for entrepreneurs, enterprises, governments and students through AI education and enablement.
LONDON, September 07, 2023--Genus (LSE:GNS), a leading global animal genetics company, today announces its preliminary results for the year ended 30 June 2023. The full report has been made available on the investors section of the Genus plc website. The Company will discuss its corporate, operational and financial highlights in a pre-recorded webcast at 7:01 AM GMT, 2.01 EST.